The Future of Farming Takes Root
Hundreds of genes are affected; different types of exercises affect unique sets of genes
Exercise in the future could be customized for individuals based on genomics, according to a study by Arizona State University (ASU) and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.Continue reading
bioSyntagma, LLC, a precision medicine company, has been awarded a nearly $200,000 Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to develop a new platform for mapping multi-omic biomarkers from single-cells in cancer patient biopsies. bioSyntagma’s Principal Scientist, Dmitry Derkach, M.D., Ph.D., is the Principal Investigator for the project. Continue reading
|
On March 15, 2018, the Arizona Senate recognized the work of the members of Arizona’s Bioscience Community with a Senate proclamation. Continue reading
Sound waves drive drug therapies to cancer cells; minimize toxicity
Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that it has received its Clinical Laboratory Permit from the New York State Department of Health, including approval for three clinical tests. The receipt of the New York permit allows patients in that state to benefit from the Company’s DecisionDx®-Melanoma, DecisionDx®-UM and DecisionDx®-PRAME molecular diagnostic tests that provide actionable molecular information to inform patient care decisions.
The National Medal of Technology and Innovation (NMTI) is now accepting nominations for 2018. Awarded by the President of the United States, the NMTI is the nation’s highest honor for technological achievement. If you know of an individual, team, or company that has made an outstanding technological contribution to United States’ economic, environmental, or social well-being, you can submit nominations until the April 6 deadline. The nomination form, a sample recommendation letter, and FAQs are available on the NMTI website.Continue reading
Destroy Pancreatic Cancer, an Atlanta-based non-profit dedicated to finding better treatments for the most deadly of all cancers, is donating $1 million for a unique pancreatic cancer clinical trial designed by the non-profit Translational Genomics Research Institute (TGen).Continue reading
